Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WR Hambrecht & Co. is an independent investment bank and financial services firm founded in 1998 by William R. Hambrecht, a pioneer in technology and life sciences venture capital. The firm is widely recognized for its proprietary "OpenIPO" platform, which utilizes a Dutch auction process to democratize the initial public offering process for both issuers and investors. While the firm operates across various sectors, it maintains a significant historical focus on emerging growth companies within the biotechnology, healthcare, and technology industries. Headquartered in San Francisco, the firm provides a range of services including equity research, asset management, and corporate advisory. WR Hambrecht & Co. is particularly noted for its role in the 2004 Google IPO and its advocacy for structural reforms in the capital markets to benefit smaller growth-stage companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WR Hambrecht & Co..